Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Foster

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Oncoimmunology|May 13, 2024
Memory-like differentiation enhances NK cell responses against colorectal cancerNancy D Marin, Michelle Becker-Hapak, Wilbur M Song, et al.
Blood|November 19, 2021
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapyMelissa M Berrien-Elliott, Michelle Becker-Hapak, Amanda F Cashen, et al.
Cancer Immunology, Immunotherapy : CII|July 3, 2024
A "Prime and Expand" strategy using the multifunctional fusion proteins to generate memory-like NK cells for cell therapyNiraj Shrestha, Michael J Dee, Pallavi Chaturvedi, et al.
Nature Communications|June 18, 2026
Inducible T-bet deletion reveals tissue-specific requirements in NKp46+ ILC immunobiology and response to murine cytomegalovirusPamela Wong, Yeeun Paik, Lily Chang, et al.
Blood|December 6, 2021
Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplantJeffrey J Bednarski, Clare Zimmerman, Melissa M Berrien-Elliott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2021
Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin LymphomaJennifer A Foltz, Brian T Hess, Veronika Bachanova, et al.
Cancer Discovery|August 23, 2020
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for LeukemiaMelissa M Berrien-Elliott, Amanda F Cashen, Celia C Cubitt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myelomaAlice Y Zhou, Nancy D Marin, Sadia Afrin, et al.
Science Immunology|June 28, 2024
Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulationJennifer A Foltz, Jennifer Tran, Pamela Wong, et al.
The Journal of Clinical Investigation|June 6, 2023
T-BET and EOMES sustain mature human NK cell identity and antitumor functionPamela Wong, Jennifer A Foltz, Lily Chang, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Oncoimmunology|May 13, 2024
Memory-like differentiation enhances NK cell responses against colorectal cancerNancy D Marin, Michelle Becker-Hapak, Wilbur M Song, et al.
Blood|November 19, 2021
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapyMelissa M Berrien-Elliott, Michelle Becker-Hapak, Amanda F Cashen, et al.
Cancer Immunology, Immunotherapy : CII|July 3, 2024
A "Prime and Expand" strategy using the multifunctional fusion proteins to generate memory-like NK cells for cell therapyNiraj Shrestha, Michael J Dee, Pallavi Chaturvedi, et al.
Nature Communications|June 18, 2026
Inducible T-bet deletion reveals tissue-specific requirements in NKp46+ ILC immunobiology and response to murine cytomegalovirusPamela Wong, Yeeun Paik, Lily Chang, et al.
Blood|December 6, 2021
Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplantJeffrey J Bednarski, Clare Zimmerman, Melissa M Berrien-Elliott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2021
Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin LymphomaJennifer A Foltz, Brian T Hess, Veronika Bachanova, et al.
Cancer Discovery|August 23, 2020
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for LeukemiaMelissa M Berrien-Elliott, Amanda F Cashen, Celia C Cubitt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myelomaAlice Y Zhou, Nancy D Marin, Sadia Afrin, et al.
Science Immunology|June 28, 2024
Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulationJennifer A Foltz, Jennifer Tran, Pamela Wong, et al.
The Journal of Clinical Investigation|June 6, 2023
T-BET and EOMES sustain mature human NK cell identity and antitumor functionPamela Wong, Jennifer A Foltz, Lily Chang, et al.
Pageof 8